Haemonetics (HAE) Reports Mixed Q1 Results; Affirms FY10 Forecast
Tweet Send to a Friend
Haemonetics Corporation (NYSE: HAE) reports Q1 EPS of $0.69, 5 cents better than the analyst estimate of $0.65. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
